Mineralys Therapeutics (MLYS) announced the appointment of Jeffrey Munsie as chief legal officer. Most recently, he served as chief legal officer and Secretary at Orbital Therapeutics, where he oversaw IP strategy, contracting, compliance, and transactions.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLYS:
- Mineralys: Advancing Lorundrostat Toward Commercialization in Uncontrolled Hypertension With Differentiated Efficacy and Safety
- Mineralys Therapeutics Charts Path After NDA Acceptance
- Mineralys Therapeutics price target raised to $51 from $46 at BofA
- Mineralys Therapeutics reports Q4 EPS (40c), consensus (52c)
- Mineralys Therapeutics Inc options imply 6.5% move in share price post-earnings